$197 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$71.09 - $85.73The lowest and highst price in the last 52 weeks.
27.85xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$2.49 (3.2%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$197 Billion|
|Enterprise Value||$221 Billion|
|Dividend Yield||$2.49 (3.2%)|
|1 Year Return||+7.3%|
|Outstanding Shares||2.53 Billion|
|Avg 30 Day Volume||11.5 Million|
|Earnings per Share||$2.78|
|Price to Sales Ratio||4.33|
|Price to Book Ratio||7.8|
|Revenue to Enterprise Value||4.66|
|EBIT to Enterprise Value||29.0|
|Total Debt to Enterprise Value||0.14|
|Debt to Equity||1.26|
|Gross Profit||$31.6 Billion|
|Net Income||$6.48 Billion|
|Quarterly Earnings Growth (YoY)||-188.9%|
|Return on Equity||25.61%|
|Return on Assets||7.08%|
|Return on Invested Capital||11.83%|
https://www.investing.com/news/stock-market-news/germanys-merck-sees-boost-from-labs-supplies-earnings-2503455Investing.com, 2 days ago
England’s drug-cost watchdog has shown a cold-shoulder to Pfizer Inc (NYSE: PFE ) and Merck KGaA’s (OTCMKTS: MKGAF) Bavencio (avelumab) as first-line maintenance therapy for urothelial cancer after...Benzinga, 3 days ago
DUBLIN , May 6, 2021 /PRNewswire/ -- The "Vaccines Market - Global Industry Analysis (2017 - 2020), Growth Trends and Market Forecast (2021 - 2025)" report has been added to ResearchAndMarkets.com'...Benzinga, 7 days ago